Long-term aspirin therapy in patients younger than 19 years is better established as a risk for influenza complications than for COVID-19 complications. The use of aspirin has been found to prevent COVID-19 mortality. Metformin has shown efficacy in reducing influenza mortality. Neither osteoporosis nor gallbladder disease has been established as a significant risk factor for influenza complications.
Each of these also places patients at risk for influenza complications:
Age younger than 2 years
Asthma
Neurologic and neurodevelopmental conditions
Blood disorders
Chronic lung disease
Any endocrine disorders
Heart disease
Kidney disease
Liver disease
Metabolic disorders
According to the CDC, several specific conditions increase a person's risk for severe COVID-19 illness:
Chronic kidney disease
Type 2 diabetes
Chronic obstructive pulmonary disease
Obesity (body mass index of 30 or more)
Immunocompromised state from solid organ transplant
Serious heart conditions, such as heart failure, coronary artery disease, or cardiomyopathies
Sickle cell disease
Learn more about influenza.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Michael Stuart Bronze. Fast Five Quiz: Influenza During the COVID-19 Pandemic - Medscape - Nov 15, 2022.
